Factory Supply 99% Purity API Powder CAS 56296-78-7 Fluoxetine Hydrochloride

Details:

                                                                       High Purity Raw Materials Powders Trimethoprim

Fluoxetine hydrochloride discovery of fluoxetine began at Eli Lilly in 1970 as a collaboration between Bryan Molloy and Robert Rathbun.
Testing the physiological effects of these compounds in mice resulted in nisoxetine, a selective norepinephrine reuptake inhibitor currently
widely used in biochemical experiments. This test which carried out by Jong-Sir Horng in May 1972, showed the compound later named
fluoxetine to be the most strong and selective inhibitor of serotonin reuptake of the series. Two years later they had to issue a correction,
admitting that the first SSRI was zimelidine developed by Arvid Carlsson and colleagues. In 1986, Fluoxetine made its appearance on the
Belgian market and was approved for use by the FDA in the United States in December 1987. Fluoxetine was the fourth SSRI to make it to
market, after zimelidine, indalpine and fluvoxamine. 

Julong Bio-Tech Co., Ltd. is located in Xi'an City, Shaanxi Province, China. It is a biotechnology enterprise engaged in the research, development,production and sales of
animal and plant extracts, cosmetics, pharmaceutical raw materials and intermediates. The company has complete experimental facilities. And advanced testing instruments
ensure the stability of product quality from all aspects. The company has a complete sales service system, the products are exported to countries all over the world, and have
won a good international reputation with excellent quality and excellent service.

The company has been adhering to the basic principles of "integrity, quality, service, and win-win" to serve customers, constantly strict requirements, set goals, and implement
win-win development.